EU Pharmaceutical Industry Starting to Incorporate More QbD-Like Elements in Applications; EU Inspectors Looking to Align Inspections with New Paradigm
This article was originally published in The Gold Sheet
Executive Summary
Quality by Design is advancing in Europe as manufacturers incorporate more QbD elements into their applications and EU regulators begin adjusting their inspections to address QbD-related issues. Decentralized review for most applications slows advance of QbD. Discussion of mock submissions spurs interest. EMEA/EFPIA meeting focuses on QbD issues companies raised privately. PDA launches PCMO initiative for sharing best practices. The increasing pain of over-inspections.